Vanguard Group
TVGN icon

Vanguard Group’s Tevogen Bio Holdings TVGN Stock Holding History

Vanguard Group’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$375K Buy
22,675
+894
+4% +$23.2K ﹤0.01% 3998
2025
Q3 		$855K Sell
21,781
-47
-0.2% -$2.31K ﹤0.01% 3832
2025
Q2 		$1.36M Buy
21,828
+1,006
+5% +$57.3K ﹤0.01% 3658
2025
Q1 		$1.12M Buy
20,822
+17,918
+617% +$1.18M ﹤0.01% 3676
2024
Q4 		$150K Sell
2,904
-90
-3% -$5.86K ﹤0.01% 4133
2024
Q3 		$55.1K Buy
2,994
+317
+12% +$9.27K ﹤0.01% 4240
2024
Q2 		$96.8K Buy
+2,677
New +$174K ﹤0.01% 4235

Other funds holding TVGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Vanguard Group's TVGN Position: Q4 2025 in Review

Vanguard Group increased its Tevogen Bio Holdings (TVGN) stake by 4.1% in Q4 2025, buying an estimated $23.2K and bringing the position to 22,675 shares worth $375K. The position accounts for ﹤0.01% of the portfolio, ranked #3998.

Vanguard Group first reported a position in TVGN in Q2 2024 and has held it in 7 quarters since. The position peaked at $1.36M in Q2 2025. 51 funds tracked by Wall St. Rank hold TVGN as of Q4 2025.

  • Vanguard Group held 22,675 shares of Tevogen Bio Holdings worth $375K as of Q4 2025.
  • Vanguard Group bought 894 Tevogen Bio Holdings shares in Q4 2025, an estimated $23.2K.
  • Tevogen Bio Holdings made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3998 holding.
  • Vanguard Group first reported a position in Tevogen Bio Holdings in Q2 2024 and has held it in 7 quarters since.
  • Vanguard Group's Tevogen Bio Holdings position peaked at $1.36M in Q2 2025.
  • 51 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.